Evidence map›Paper›PMID 41969506›Full record

ArticleTranslational cancer research2026

Experimental study of ultrasound combined with microbubbles augmenting the sonodynamic therapy of 5-aminolevulinic acid in glioma cells.

Yong He, Qiong Sun, Qian Wan, Chang Zhou, Rong Liu, Jun Zhou

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yong HeDepartment of Ultrasound, Yichang Central People's Hospital (First Clinical Medical College of Three Gorges University), Yichang, China.
Qiong SunDepartment of Geriatrics, Yichang City Mental Health Center, Yichang, China.
Qian WanShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Chang ZhouDepartment of Ultrasound, Yichang Central People's Hospital (First Clinical Medical College of Three Gorges University), Yichang, China.
Rong LiuDepartment of Ultrasound, Yichang Central People's Hospital (First Clinical Medical College of Three Gorges University), Yichang, China.
Jun ZhouDepartment of Ultrasound, Yichang Second People's Hospital (Second Clinical Medical College of Three Gorges University), Yichang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sonodynamic therapy (SDT) is a promising non-invasive modality for cancer treatment. This Methods: Results: Flow cytometry and CLSM results indicated that the level of protoporphyrin IX (PpIX) in cells was significantly enhanced after treatment with US combined with MBs and 5-ALA (US-MBs-5-ALA group). MTS analysis demonstrated that the cell viability was significantly reduced in the US-MBs-5-ALA group. Qualitative observations from TEM revealed that mitochondria in cells subjected to low-intensity US treatment alone showed swelling and vacuolization. Upon combined treatment with US and 5-ALA, cells exhibited apoptotic features such as nuclear condensation and crescent-shaped structures. Moreover, mitochondrial damage was more severe in the US-MBs-5-ALA group. Qualitative analysis by CLSM showed that the level of ROS in the US-MBs-5-ALA group was significantly increased. These results suggest a mechanistic link where US-MBs enhance 5-ALA uptake, leading to increased ROS generation under sonication, which in turn induces mitochondrial damage and promotes cytotoxicity. Conclusions: These preliminary

Indexed as

5-aminolevulinic acid (5-ALA)gliomamicrobubbles (MBs)sonodynamic therapy (SDT)Ultrasound (US)

Identifiers

PMID41969506
PMCPMC13067035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.